Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

NCT01017536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
HIV Infections

Interventions

BIOLOGICAL: AERAS-402
BIOLOGICAL: Placebo

Sponsor

Aeras

Collaborators

[object Object]